{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:49:20Z","timestamp":1785476960586,"version":"3.56.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.14283\/jpad.2020.63","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T05:56:41Z","timestamp":1614232601000},"page":"123-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Application of Digital Cognitive Biomarkers for Alzheimer's Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline"],"prefix":"10.1016","volume":"8","author":[{"given":"J.R.","family":"Bock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.R.","family":"Shankle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.14283\/jpad.2020.63_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","article-title":"Alzheimer's disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimers Dement (N Y)."},{"issue":"s1","key":"10.14283\/jpad.2020.63_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JAD-179901","article-title":"Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future","volume":"64","author":"Cummings","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2020.63_bib3","author":"Food and Drug Administration"},{"issue":"2","key":"10.14283\/jpad.2020.63_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.trci.2017.02.004","article-title":"Recruiting to preclinical Alzheimer's disease clinical trials through registries","volume":"3","author":"Grill","year":"2017","journal-title":"Alzheimers Dement (N Y)."},{"issue":"1","key":"10.14283\/jpad.2020.63_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamapsychiatry.2017.3391","article-title":"Association of Cerebral Amyloid-\u03b2 Aggregation With Cognitive Functioning in Persons Without Dementia","volume":"75","author":"Jansen","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.14283\/jpad.2020.63_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jalz.2018.12.007","article-title":"GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies","volume":"15","author":"Langbaum","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.14283\/jpad.2020.63_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40263-018-0598-1","article-title":"Alzheimer's Disease Clinical Trials: Moving Toward Successful Prevention","volume":"33","author":"Rafii","year":"2019","journal-title":"CNS Drugs"},{"issue":"12","key":"10.14283\/jpad.2020.63_bib8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1212\/WNL.0000000000003126","article-title":"Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration","volume":"87","author":"Wolz","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2020.63_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13195-019-0576-y","article-title":"Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings","volume":"12","author":"Vermunt","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2020.63_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"AIBL, ADNI, ADCS, the preclinical Alzheimer cognitive composite: measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.14283\/jpad.2020.63_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/jnnp-2015-312383","article-title":"ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials","volume":"87","author":"Wang","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.14283\/jpad.2020.63_bib12","first-page":"102328","article-title":"An application of multinomial processing tree models and Bayesian methods to understanding memory impairment. J. Math","volume":"95","author":"Lee","year":"2020","journal-title":"Psych"},{"key":"10.14283\/jpad.2020.63_bib13","unstructured":"Shankle WR, Hara J, Bock JR, Fortier D, Mangrola T, Lee MD, Alexander GE, Batchelder WH, Petersen RC, Kremers W. Using Graphical Hierarchical Bayesian Cognitive Process Models Applied to Common Memory Tests to Predict AD Pathology within Normal Subjects. 2018. Clinical Trial in Alzheimer's Disease. Poster Presentation. Barcelona, November 2018."},{"issue":"4","key":"10.14283\/jpad.2020.63_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00115-012-3688-1","article-title":"[Pathogenesis and prevention of Alzheimer's disease: when and in what way does the pathological process begin?]","volume":"84","author":"Braak","year":"2013","journal-title":"Nervenarzt"},{"issue":"1","key":"10.14283\/jpad.2020.63_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.expneurol.2007.07.006","article-title":"Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms","volume":"209","author":"Halliday","year":"2008","journal-title":"Exp Neurol"},{"issue":"7595","key":"10.14283\/jpad.2020.63_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature17172","article-title":"Memory Retrieval by Activating Engram Cells in Mouse Models of Early Alzheimer's Disease","volume":"531","author":"Roy","year":"2016","journal-title":"Nature"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724003807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724003807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:12:17Z","timestamp":1737339137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724003807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2274580724003807"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2020.63","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of Digital Cognitive Biomarkers for Alzheimer's Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2020.63","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}